FDA Adverse Event
Injury
Summary report: N
SPRINT QUATTRO
MDR report key: 3153239
·
Received June 8, 2013
Report
- Report Number
- 2649622-2013-05901
- Event Type
- Injury
- Date Received
- June 8, 2013
- Date of Event
- March 15, 2013
- Report Date
- March 15, 2013
- Manufacturer
- MPRI
- Product Code
- LWS
- PMA / PMN Number
- P920015
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PRODUCT: 5076-52 IMPLANTABLE PACING LEAD (B)(6) 2013 ; D314DRG IMPLANTABLE PACEMAKER/CARDIO/DEFIB (B)(6) 2013. (B)(4).
Description of Event or Problem · 1
IT WAS REPORTED THAT THE PATIENT DEVELOPED PLEURAL EFFUSION TWO TO THREE WEEKS POST IMPLANTATION. THE PHYSICIAN QUESTIONED IF THERE WAS PERFORATION BUT WAS UNABLE TO VERIFY ON X-RAY, ECHO, OR CT (COMPUTED TOMOGRAPHY). THEREFORE BOTH, THE ATRIAL AND RIGHT VENTRICULAR LEADS, WERE REPOSITIONED AND REMAIN IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 256084 | SPRINT QUATTRO | DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER | LWS | MPRI | 694765 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00029 YR | Hospitalization| L| R |